AU2001221695A1 - Solid pharmaceutical compositions for controlled release of active substances - Google Patents

Solid pharmaceutical compositions for controlled release of active substances

Info

Publication number
AU2001221695A1
AU2001221695A1 AU2001221695A AU2169501A AU2001221695A1 AU 2001221695 A1 AU2001221695 A1 AU 2001221695A1 AU 2001221695 A AU2001221695 A AU 2001221695A AU 2169501 A AU2169501 A AU 2169501A AU 2001221695 A1 AU2001221695 A1 AU 2001221695A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
controlled release
active substances
solid pharmaceutical
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001221695A
Inventor
Monique Berwaer
Michel Deleers
Domenico Fanara
Anthony Guichaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of AU2001221695A1 publication Critical patent/AU2001221695A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
AU2001221695A 2000-01-14 2000-12-20 Solid pharmaceutical compositions for controlled release of active substances Abandoned AU2001221695A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00100721A EP1118321A1 (en) 2000-01-14 2000-01-14 Solid pharmaceutical compositions for the controlled delivery of active substances
EP00100721 2000-01-14
PCT/EP2000/013038 WO2001051033A1 (en) 2000-01-14 2000-12-20 Solid pharmaceutical compositions for controlled release of active substances

Publications (1)

Publication Number Publication Date
AU2001221695A1 true AU2001221695A1 (en) 2001-07-24

Family

ID=8167618

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001221695A Abandoned AU2001221695A1 (en) 2000-01-14 2000-12-20 Solid pharmaceutical compositions for controlled release of active substances

Country Status (3)

Country Link
EP (1) EP1118321A1 (en)
AU (1) AU2001221695A1 (en)
WO (1) WO2001051033A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
ES2285088T3 (en) * 2002-01-09 2007-11-16 Ucb Farchim S.A. PHARMACEUTICAL COMPOSITIONS OF MODIFIED LIBERATION.
WO2003103634A1 (en) * 2002-06-07 2003-12-18 Ranbaxy Laboratories Limited Sustained release oral dosage forms of gabapentin
DE05815688T1 (en) 2005-01-27 2008-06-26 Alembic Ltd. LEVETIRACETAM FORMULATION WITH EXTENDED RELEASE
US8431156B2 (en) 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
US8216611B2 (en) * 2005-03-30 2012-07-10 Mylan Pharmaceuticals Ulc Combined-step process for pharmaceutical compositions
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
TR200905670A1 (en) 2009-07-22 2011-02-21 Sanovel �La� San.Ve T�C.A.�. Levetiracetam pharmaceutical compositions for prolonged release
EP2298290A1 (en) 2009-09-16 2011-03-23 LEK Pharmaceuticals d.d. Controlled release composition comprising levetiracetam
WO2013089986A1 (en) * 2011-12-12 2013-06-20 Product And Technology Partners Llc Improved denaturants for sympathomimetic amines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1106728A (en) * 1965-05-25 1968-03-20 Ciba Ltd Diuretic and saliuretic sustained-release compositions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
DE3524572A1 (en) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K SOLID PHARMACEUTICAL FORMS FOR PERORAL USE CONTAINING 9-DEOXO-11-DEOXY-9,11- (IMINO (2- (2-METHOXYETHOXY) ETHYLIDEN) -OXY) - (9S) -ERYTHROMYCIN AND METHOD FOR THE PRODUCTION THEREOF
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
CZ298212B6 (en) * 1996-05-13 2007-07-25 Novartis Consumer Health S. A. Slowly erodible lozenge
BE1011045A3 (en) * 1997-03-14 1999-04-06 Ucb Sa Pharmaceutical composition for controlled release of active substances.

Also Published As

Publication number Publication date
EP1118321A1 (en) 2001-07-25
WO2001051033A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU2093101A (en) Compositions for efficient release of active ingredients
AU2002229140A1 (en) Controlled release pharmaceutical composition
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
AU2001286677A1 (en) Controlled release of substances
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
AU2003213151A1 (en) Controlled release solid dosage carbamazepine formulations
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
EP1189597A4 (en) Oil-core compositions for the sustained release of hydrophobic drugs
AU2001287977A1 (en) Controlled release formulations for oral administration
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
HUP0302522A3 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
AU4213299A (en) Controlled release of substances
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AU6386801A (en) System for the release of active ingredients
AU2001232948A1 (en) Controlled release of drugs
AU5820900A (en) Capsule for the controlled release of active substances
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds